We are live on ! Find out more
KBC Group

KBC Group Portfolio holdings

AUM $46.3B Turnover 4.85%
1-Year Est. Return 43.9%
This Fund
S&P 500
This Quarter Est. Return
+4.94%
1 Year Est. Return
+43.9%
3 Year Est. Return
+135.96%
5 Year Est. Return
+174.68%
10 Year Est. Return
+647.83%
AUM
$43.9B
AUM Growth
+$2.15B
Cap. Flow
+$941M
Cap. Flow %
2.15%
Top 10 Hldgs %
38.78%
Holding
1,752
New
25
Increased
441
Reduced
297
Closed
24
Avg Time Held
5.6 years
Top 10 Avg Time Held
4.6 years
Top 20 Avg Time Held
3.4 years

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$166M
2
MU icon
Micron Technology
MU
+$148M
3
FERG icon
Ferguson
FERG
+$131M
4
AMD icon
Advanced Micro Devices
AMD
+$107M
5
GEV icon
GE Vernova
GEV
+$94.9M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$262M
2
TMUS icon
T-Mobile US
TMUS
+$167M
3
VZ icon
Verizon
VZ
+$114M
4
NFLX icon
Netflix
NFLX
+$84.4M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$74.2M

Sector Composition

Rank Sector Weight
1 Technology 34.5%
2 Healthcare 13.82%
3 Communication Services 13.35%
4 Financials 13.33%
5 Consumer Discretionary 9.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CENTA icon
1526
Central Garden & Pet Co Class A
CENTA
$2.27B
$66K ﹤0.01%
2,255
– –
2022 Q1
15 quarters
HTH icon
1527
Hilltop Holdings
HTH
$2.11B
$66K ﹤0.01%
1,945
– –
2019 Q3
25 quarters
IOSP icon
1528
Innospec
IOSP
$2.37B
$66K ﹤0.01%
860
– –
2020 Q1
23 quarters
KNTK icon
1529
Kinetik
KNTK
$4.42B
$66K ﹤0.01%
1,825
– –
2025 Q1
3 quarters
RNG icon
1530
RingCentral
RNG
$6.32B
$66K ﹤0.01%
2,279
– –
2023 Q3
9 quarters
AORT icon
1531
Artivion
AORT
$1.06B
$65K ﹤0.01%
+1,417
New +$63.1K
2025 Q4
0 quarters
CLDX icon
1532
Celldex Therapeutics
CLDX
$2.18B
$65K ﹤0.01%
2,411
– –
2024 Q1
7 quarters
MD icon
1533
Pediatrix Medical
MD
$2.22B
$65K ﹤0.01%
+3,054
New +$62.6K
2025 Q4
0 quarters
NOG icon
1534
Northern Oil and Gas
NOG
$2.89B
$65K ﹤0.01%
3,034
– –
2023 Q1
11 quarters
VSH icon
1535
Vishay Intertechnology
VSH
$4.29B
$65K ﹤0.01%
4,483
– –
2023 Q3
9 quarters
WGS icon
1536
GeneDx Holdings
WGS
$1.88B
$65K ﹤0.01%
503
– –
2025 Q1
3 quarters
WOR icon
1537
Worthington Enterprises
WOR
$3.14B
$65K ﹤0.01%
1,262
– –
2023 Q3
9 quarters
TIC icon
1538
TIC Solutions Inc
TIC
$1.88B
$65K ﹤0.01%
6,436
– –
2025 Q3
1 quarter
ADNT icon
1539
Adient
ADNT
$1.39B
$64K ﹤0.01%
3,331
– –
2025 Q3
1 quarter
ALKT icon
1540
Alkami Technology
ALKT
$1.47B
$64K ﹤0.01%
2,766
– –
2025 Q1
3 quarters
CNK icon
1541
Cinemark Holdings
CNK
$4.46B
$64K ﹤0.01%
2,762
– –
2022 Q2
14 quarters
FCF icon
1542
First Commonwealth Financial
FCF
$2.05B
$64K ﹤0.01%
3,772
– –
2022 Q2
14 quarters
KN icon
1543
Knowles
KN
$2.88B
$64K ﹤0.01%
2,988
– –
2018 Q3
29 quarters
MBC icon
1544
MasterBrand
MBC
$1.37B
$64K ﹤0.01%
5,800
– –
2022 Q4
12 quarters
LOAR icon
1545
Loar Holdings
LOAR
$5.82B
$64K ﹤0.01%
947
– –
2025 Q2
2 quarters
BUR icon
1546
Burford Capital
BUR
$668M
$63K ﹤0.01%
7,104
– –
2025 Q2
2 quarters
CIVI icon
1547
DELISTED
Civitas Resources
CIVI
$63K ﹤0.01%
2,325
– –
2022 Q2
14 quarters
DK icon
1548
Delek US
DK
$4.68B
$63K ﹤0.01%
2,125
– –
2024 Q2
6 quarters
NWBI icon
1549
Northwest Bancshares
NWBI
$2.18B
$63K ﹤0.01%
5,227
– –
2021 Q2
18 quarters
NWN icon
1550
Northwest Natural Holdings
NWN
$2.06B
$63K ﹤0.01%
1,341
– –
2022 Q1
15 quarters

Similar funds

KBC Group's Q4 2025 Portfolio in Review

As of Q4 2025, KBC Group held 1,752 positions worth $43.9B, up 5.2% from $41.7B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Trading was light in Q4 2025: portfolio turnover was 2.8%. KBC Group opened 25 new positions and exited 24, leaving the 1,752-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 36% a quarter earlier, followed by Healthcare and Communication Services.

  • KBC Group's largest Q4 2025 buy was Qnity Electronics Inc: 149,289 shares worth $12.2M.
  • KBC Group added most to Abbott in Q4 2025, an estimated $166M increase.
  • KBC Group's biggest Q4 2025 reduction was T-Mobile US, cutting an estimated $167M.
  • KBC Group fully exited AbbVie in Q4 2025, selling an estimated $262M.
  • KBC Group's ten largest holdings make up 39% of its $43.9B portfolio in Q4 2025.
  • KBC Group opened 25 new positions and closed 24 in Q4 2025.
  • KBC Group's portfolio value rose 5.2% quarter-over-quarter to $43.9B.

Based on KBC Group's 13F filing for Q4 2025, filed 26 Jan 2026.